Background-The rates of depression in adults with cancer have been reported as high as 38%-58%. How depression affects overall health care expenditures in individuals with cancer is an under-researched area.
Diagnosis of cancer in adults is often accompanied by negative emotional health, distress, anxiety, and fear of death, 1 which is why co-occurring depression is not uncommon in adults with cancer. Previous studies have documented high rates of depression in this population, [2] [3] [4] ranging from 58% in hospitalized terminally ill patients with mixed cancers 5 to 38% in patients with pancreatic cancer. 6 Co-occurring depression and cancer may affect the morbidity of cancer patients [7] [8] [9] [10] [11] -those with depression and cancer are less likely to follow treatment regimens, [12] [13] [14] and more likely to have other comorbidities such as diabetes, cardiovascular disease, and musculoskeletal conditions. 15, 16 All of these factors may lead to increased health care utilization and expenditures in those with depression compared with those without depression. It is plausible that cancer patients with depression may not adhere to cancer treatments, 8, 17 thereby increasing their health care expenditures.
Despite the comorbidity burden of depression, there is scant literature examining the incremental cost burden of depression in adults with cancer. A study that investigated the prevalence and incremental expenditures of depression in elderly patients (>65 years) with prostate cancer patients used data from the 1995-2003 Surveillance, Epidemiology and End Results (SEER) cancer registry (13 SEER sites) linked with Medicare claims. 18 That study found that 8.5% of the patients were diagnosed with depression after their cancer diagnosis. It also found that the elderly patients with depression during treatment were more likely to have emergency department visits (adjusted odds ratio [AOR], 4.45), hospitalizations (AOR, 3.22), outpatient visits (AOR, 1.71), and higher medical care expenditures (AOR, 1.52) during the first year of treatment, compared with their counterparts without depression. Although this study highlighted the excess health care expenditures associated with depression in cancer patients, it included only elderly men aged 66 years or older and enrolled in fee-for-service Medicare. The study results were limited by their lack of generalizability. Another study that analyzed claims data of all military health care beneficiaries with cancer found that 12.6% had depression after cancer diagnosis and cooccurring depression was associated with higher health care utilization and higher annual health care expenditures ($16,212) in cancer patients with depression compared with those without depression ($7,728). 19 The study was not able to control for factors such as other comorbidities, which can also affect health care expenditures, and thus might have overestimated the excess expenditures associated with depression. Moreover, the study included military populations and may therefore not be representative of the US population. To date, no clear and aggregated picture has emerged in the United States about the magnitude of health care expenditures associated with depression in younger adult cancer survivors who are older than 21 years. It is not known whether individuals with cancer and depression have greater health service utilization and higher health care expenditures compared with those without depression, after controlling for health status variables. Therefore, the primary objective of this study was to estimate excess health care utilization and expenditures associated with depression in adult cancer survivors older than 21 years, after controlling for demographic, socio-economic, access to care, other co-occurring conditions, and health status variables.
Other independent variables-Demographic variables included gender (women, men), categories of age in years (22-49, 50-64, ≥65), race/ethnicity (white, African American, Latino, and other), marital status (married, widowed, separated/divorced, and never married) and area of residence (metro and nonmetro). Socioeconomic factors were categorized by education (less than high school, high school, and above high school), and poverty status. The poverty status variable available from the MEPS was defined as poor (<100% federal poverty line), near poor (100% to < 200%), middle income (200% to < 400%), and high income (≥400%) and represented family income in relation to the federal poverty line (based on family size and composition).
Health status was measured with standard scales of perceived physical and mental health. Perceived physical and mental health status were categorized into excellent/very good, good, fair/ poor. Lifestyle risk factors were indicated by body mass index categories (BMI; normal or underweight, overweight, and obese) and current smoking (Yes/No). Health care expenditures are often influenced by the presence of chronic physical conditions such as arthritis, chronic obstructive pulmonary disease (COPD), gastro esophageal reflux disease (GERD), other endocrine disease, osteoporosis, and mental health conditions such as depression and anxiety. Therefore, we also included the total number of co-occurring chronic conditions as one of the independent variables.
Statistical analysis
In our statistical analysis, chi-square tests were conducted to assess the univariate association between presence of depression and an individual's characteristics. We performed t tests to assess significant differences in expenditures in individuals with and without depression. Health care expenditures were converted to 2009 dollars based on the consumer price index for medical care services from the bureau of labor statistics. 22 Average and standard error of expenditures for outpatient use and prescription drug use were compared by presence or absence of depression. The average and standard error of expenditures for users of specific health care services (inpatient, emergency department and other health service uses) were also compared.
Because expenditure data are positively skewed, a natural logarithm transformation was used to normalize health care expenditures. 23 Ordinary least squares (OLS) regressions on logged expenditures were conducted to determine the excess expenditures associated with depression after controlling for gender, race/ethnicity, age, marital status, metro status, education, employment, poverty status, health insurance coverage, usual source of care, perceived physical and mental health, cardiovascular disease, number of other conditions, anxiety, BMI categories, smoking status, and year of observation. Parameter estimates of categorical independent variables from OLS regression model could be interpreted as percentage change for each unit of change in the independent variable (ie, percentage change = eβ−1). 24 In secondary analyses, generalized linear models (GLM) with log-link function and Gaussian distribution were used to estimate cost. Because the GLM performs transformation of the mean cost directly instead of transforming cost data, the reverse transformation will generate no bias in the estimated mean cost. To calculate the incremental expenditures associated with depression, we added the intercept and the coefficient for depression and exponentiated the sum to directly arrive at expenditures for adult cancer survivors with depression. We exponentiated the intercept term to calculate expenditures for cancer patients without depression. The differences in these 2 estimates were reported as incremental average cost (ie, arithmetic mean) associated with depression in adult cancer survivors.
Multivariable logistic regression models were used to determine the association between depression and the likelihood of using inpatient services, emergency department and other services. In this article, AORs and 95% confidence intervals (CIs) of depression were reported. In addition, we conducted OLS regression of inpatient, emergency department, and other expenditures only in users. The sample design of the MEPS data is complex with stratification, clustering and multistage selection. All analyses using both SAS 9.3 and STATA 12 accounted for this complex survey design.
Results

Description of the study sample
The study sample consisted of 4,766 adults reported with cancer during 2006-2009. Fourteen percent (weighted) of adult cancer survivors reported depression. In cancer patients with depression, we found that 76.3% used antidepressants. Univariate associations of individual characteristics with the presence of depression are shown in Table 1 . Except for race/ethnicity, age, health insurance type, and usual source of care, all characteristics were significantly associated with presence of depression. For example, 17% of women reported depression, compared with 10% of men. Fewer individuals with excellent and very good mental health status reported depression (8.7%), compared with individuals with good (11.4%) or fair/poor (26.1%) health status. More individuals with cardiovascular disease expenditures for those with depression were significantly greater than those without depression. For example, in patients who used inpatient services, depression was associated with 14% greater inpatient expenditures. Similarly, in patients who used emergency department services, depression was associated with 10% greater emergency department expenditures.
Discussion
We used the MEPS database, a nationally representative survey of the US noninstitutionalized civilian population, to estimate excess expenditures and health care use in adult cancer survivors. The rate of depression in our study sample (14%) is close to the prevalence rate of depression (12.6%) in cancer survivors of all cancer types in a military health system. 19 However, our estimated rate of depression is higher than the prevalence rate of depression (8.5%) in elderly prostate cancer patients from SEER-cancer registries. 18 These differences are plausible because depression may vary by age, gender, and cancer type. Depression prevalence was reported to be as high as 38% in pancreatic cancer patients, 14%-40% in breast cancer patients, and 4.7%-33% in lung cancer patients. 2 In our study, we found that the presence of depression was associated with greater unadjusted and adjusted average total expenditures (31.7%) as well as outpatient and prescription drug expenditures (16.2% and 107.1%, respectively). These findings are consistent with those in 2 aforementioned studies. 18, 19 Presence of depression was associated with 110% higher expenditures in military beneficiaries. Findings from our study confirm the excess burden of depression for third-party payors as well as families. Because many of the recent policy efforts have focused on containing cost, 25, 26 future research should examine whether treating depression may result in cost reductions for cancer survivors with depression.
The current findings highlight the need for routine depression screening in cancer patients and the treatment of depression before it becomes severe. Because there is much uncertainty about how to treat depression in patients with cancer, 27, 28 oncologists and physicians might not prioritize its treatment while they are managing the patient with cancer. Indeed, a cancer diagnosis is considered a major life-changing event, and the focus on the disease often consumes the patients and the oncologist, and awareness of and concerns about depression may be crowded out. [29] [30] [31] It is complicated to know definitively whether treating depression leads to a reduction in health costs. Our literature review suggests that depression treatment may or may not reduce health care expenditures in individuals with chronic conditions. [32] [33] [34] [35] [36] Although these studies are not specific to cancer, future research needs to examine whether depression treatment in adults with cancer and depression results in reduced health care expenditures.
Our study findings also highlighted excess burden in terms of emergency department use and expenditures associated with depression because adult cancer survivors were more likely to use emergency department services. These results are similar to findings seen earlier in the literature that breast, lung and colon cancer Medicare beneficiaries with depressive syndrome were more likely to use acute medical services such as emergency department (AOR, 2.12-3.16). 37 There are some plausible explanations for the findings. A study found that cancer patients with depressive disorder and depressive symptoms had a higher risk of attempting suicide compared with those without depression. 38 Adults who are at immediate risk for attempting suicide require emergency care and prompt treatment for depression. In addition, adults with cancer who are depressed are less likely to be adherent to medications. [12] [13] [14] The nonadherence may result in worse cancer prognosis and poor outcomes, thereby leading to more emergency department visits. 39 In addition, depression was not associated with a greater likelihood of use of inpatient services, but it was associated with greater inpatient expenditure for inpatient services. Inpatient expenditures in adult cancer survivors were 14% higher in those with depression compared with those without depression. These findings suggest that those with depression may have greater length of hospital stay or burden of illness that may contribute to increased expenditures when they are hospitalized. In a study not specific to cancer and based on the Longitudinal Aging Study Amsterdam, it was found that depression was associated with greater lengths of hospital stay compared with those without depression. 40 Although the association between depression and length of stay was partly explained by other variables such as comorbid conditions, functional status, alcohol use, and smoking, depression was independently associated with greater lengths of inpatient stay. Similar findings were observed in a Western Australian study that used a prospective cohort of men. 41 Our study included extensive adjustments for perceived physical and mental health, cardiovascular disease, number of other conditions, anxiety, and BMI. However, we cannot rule out the possibility that patients with depression may have complex comorbidities compared with those without depression and that some of the increased expenditures associated with depression could be a result of these complexities.
Our study findings need to be interpreted in the light of its strengths and limitations. We used a nationally representative sample of adult cancer survivors, adjusted for a comprehensive list of factors that may affect health care expenditures. We extended the existing literature by examining type of health care utilization and its relationship to presence of depression. There are some limitations that may affect the interpretation of the study results. First, the study used a cross-sectional study design. We reported co-occurring rate of depression in individuals with cancer. Findings from a previous study demonstrated that individuals with cancer may be at an elevated risk for depression. 3 Second, we included all cancer types in our analysis to provide an aggregate view of excess financial burden of depression in cancer survivors. We were not able to analyze the burden for each cancer type because of the small sample size. Third, depression was from self-report in the MEPS database. There is no diagnostic instrument used by the MEPS to validate the depression diagnosis. It may be possible that depression was underestimated and those with depression may be classified in the no depression group. Because of a misclassification issue, our estimates of incremental burden of depression in individuals with cancer may be conservative. Fourth, we analyzed data only for living cancer patients. Those who died during the reporting year were excluded. As the costs of end-of-life care are high, we might have underestimated the financial burden of depression.
Our study has important implications for clinicians, scientists, and policy makers. As far as we know, it is the first study to provide a national estimate of depression prevalence in cancer patients, and the health care expenditures and utilization associated with depression. The findings suggest that future policy efforts are needed to reduce excess health care expenditures associated with depression in cancer patients. The efforts include screening for depressive symptoms, preventing major depression, and timely treatment for depression. The findings also emphasize the importance of the coordination of care in psycho-oncology. All cancer centers accredited by the American College of Surgeon's Commission on Cancer are required to have a plan to integrate psychosocial services into their cancer care. 42 It is expected that much training and consultation are needed for oncologists to develop their integration programs. Future research is also needed to assess the effectiveness of treatments in this comorbidity population. AOR, adjusted odds ratio; CI, confidence interval; ED, emergency room; OLS, ordinary least squares *** P < .001 ** .001 ≤ P < .01
* .01 ≤ P < .05
